RT @Deprescribing: “This further supports #deprescribing as a possible imperative to improve health outcomes in older adults” Study explore…
RT @Deprescribing: “This further supports #deprescribing as a possible imperative to improve health outcomes in older adults” Study explore…
RT @Deprescribing: “This further supports #deprescribing as a possible imperative to improve health outcomes in older adults” Study explore…
RT @OptimisingRxUse: Wow - pharmacist-led #deprescribing in NZ nursing homes reduced: number of medications falls adverse drug events depre…
“This further supports #deprescribing as a possible imperative to improve health outcomes in older adults” Study explores deprescribing anticholinergic and sedative medicines in order to improve cognitive and physical function https://t.co/SbWaqqJMcB
RT @OptimisingRxUse: Wow - pharmacist-led #deprescribing in NZ nursing homes reduced: number of medications falls adverse drug events depre…
RT @OptimisingRxUse: Wow - pharmacist-led #deprescribing in NZ nursing homes reduced: number of medications falls adverse drug events depre…
RT @OptimisingRxUse: Wow - pharmacist-led #deprescribing in NZ nursing homes reduced: number of medications falls adverse drug events depre…
RT @OptimisingRxUse: Wow - pharmacist-led #deprescribing in NZ nursing homes reduced: number of medications falls adverse drug events depre…
RT @OptimisingRxUse: Wow - pharmacist-led #deprescribing in NZ nursing homes reduced: number of medications falls adverse drug events depre…
RT @OptimisingRxUse: Wow - pharmacist-led #deprescribing in NZ nursing homes reduced: number of medications falls adverse drug events depre…
RT @OptimisingRxUse: Wow - pharmacist-led #deprescribing in NZ nursing homes reduced: number of medications falls adverse drug events depre…
RT @Nailabouni4: First deprescribing study in older people living in residential care facilities in New Zealand is published! 🙂 Read it her…
RT @OptimisingRxUse: Wow - pharmacist-led #deprescribing in NZ nursing homes reduced: number of medications falls adverse drug events depre…
Wow - pharmacist-led #deprescribing in NZ nursing homes reduced: number of medications falls adverse drug events depression scores frailty scores DBI score ...All within 6-months of the intervention @DeprescribeNet @SaferMedsNL @Patient_Safety
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @UIRxPalli8rs: DEFEAT-polypharmacy: deprescribing anticholinergic & sedative medicines in long-term care - https://t.co/ioCg2lXOBz #Twit…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
DEFEAT-polypharmacy: deprescribing anticholinergic & sedative medicines in long-term care - https://t.co/ioCg2lXOBz #TwitteRx
RT @SoarBeyondLtd: Important to understand importance of polypharmacy and anticholinergic burden in patients. Did you know our @i2iPharmaci…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
This guide is useful but probably needs updating https://t.co/7hnVvhAspn
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
We should be using research like this to justify support and follow up at time of prescribing. If you know the problem the best option is to prevent it. #deprescribing #pharmacists #medicines #Pharmacy
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
Important to understand importance of polypharmacy and anticholinergic burden in patients. Did you know our @i2iPharmacist resources including relevant and useful resources re managing frailty & drugs for #GPPharmacists - see workshop 28th March in Bir
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
RT @Deprescribing: Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patien…
Recent article discusses the benefits and feasibility of reducing anticholinergic and sedative medicines in older patients “#deprescribing showed signals of significant benefits across a range of important health outcomes including mood, frailty and falls”
RT @emanias1: Deprescribing intervention by pharmacists in RACFs led to a reduction in residents' falls, adverse drug reactions, depression…
RT @emanias1: Deprescribing intervention by pharmacists in RACFs led to a reduction in residents' falls, adverse drug reactions, depression…
Deprescribing intervention by pharmacists in RACFs led to a reduction in residents' falls, adverse drug reactions, depression scores and frailty scores 6 months after deprescribing intervention. #Deprescribing https://t.co/Mh0g9W4h7r
[IJCP] DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities https://t.co/uF1e34t2Rn
RT @DRugby56: DEFEAT-polypharmacy: #deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilit…
DEFEAT-polypharmacy: #deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities https://t.co/8zKJspW7Z1
RT @Inma16: (Int J Clin Pharm) DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential a…
RT @Inma16: (Int J Clin Pharm) DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential a…
RT @Nailabouni4: First deprescribing study in older people living in residential care facilities in New Zealand is published! 🙂 Read it her…
RT @Nailabouni4: First deprescribing study in older people living in residential care facilities in New Zealand is published! 🙂 Read it her…
RT @Inma16: (Int J Clin Pharm) DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential a…
RT @Nailabouni4: First deprescribing study in older people living in residential care facilities in New Zealand is published! 🙂 Read it her…
RT @Inma16: (Int J Clin Pharm) DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential a…
RT @Inma16: (Int J Clin Pharm) DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential a…
(Int J Clin Pharm) DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. https://t.co/t4ABdAErPV
First deprescribing study in older people living in residential care facilities in New Zealand is published! 🙂 Read it here https://t.co/Gn2H0Ahh3W
RT @danisevisan: DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facil…
RT @danisevisan: DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facil…
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities https://t.co/GBSjh2zXhe